Jay Pearson MPH, Ph.D.

Jay Pearson Headshot

Affiliated Faculty

Jay Pearson, MPH, Ph.D.

Focus Areas
Degrees

PhD, Health Behavior and Health Education, University of Michigan

MPH, Health Behavior and Health Education, University of North Carolina at Chapel Hill

BS, Community Health Education, North Carolina Central University

Jay A. Pearson’s research, teaching and advocacy address how policy sponsored and structurally rooted social inequality influence the social determination of health disadvantage. A native of Hertford County North Carolina, Pearson’s early experiences in the rural agricultural south shaped and informed his professional interests. Pearson began his public health career as a U.S. Peace Corps Volunteer in Honduras where he worked as a child survival health specialist training and evaluating midwives and local health workers.

Upon returning to the U.S. he worked as a health educator with the East Coast Migrant Health Project, later designing and implementing health and safety training for Spanish-speaking factory workers, pesticide safety training with a multi-ethnic farm worker population, and lead poisoning prevention in an impoverished urban community. Pearson served as assistant project director of an NIH-funded research study in which he was responsible for primary data collection in an ethnically diverse Detroit community.

Academically, Pearson moved from a model of individual behavior change in undergraduate studies at North Carolina Central University to one of community assessment and intervention during his masters’ work at the University of North Carolina. While pursuing his doctoral degree at the University of Michigan, Pearson began to study the social determinants of population health. He is particularly interested in the health effects of conventional and non-conventional resources associated with racial assignment, ethnic identity, national origin, immigration, and cultural orientations.

Kaye DR, Lee H-J, Gordee A, George DJ, Ubel PA, Scales CD, et al. Medication Payments by Insurers and Patients for the Treatment of Metastatic Castrate-Resistant Prostate Cancer. JCO Oncol Pract. 2023 Apr;19(4):e600–17.

Dzimitrowicz HE, Wilson LE, Jackson BE, Spees LP, Baggett CD, Greiner MA, et al. End-of-Life Care for Patients With Metastatic Renal Cell Carcinoma in the Era of Oral Anticancer Therapy. JCO oncology practice. 2023 Feb;19(2):e213–27.

Dinan MA, Wilson LE, Greiner MA, Spees LP, Pritchard JE, Zhang T, et al. Oral Anticancer Agent (OAA) Adherence and Survival in Elderly Patients With Metastatic Renal Cell Carcinoma (mRCC). Urology. 2022 Oct;168:129–36.